Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1530/eje.0.1370205
European Journal of Endocrinology, Vol 137, Issue 2, 205-208
Copyright © 1997 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wingrove, C.
Right arrow Articles by Stevenson, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wingrove, C.
Right arrow Articles by Stevenson, J.
Articles

17 beta-Oestradiol inhibits stimulated endothelin release in human vascular endothelial cells

CS Wingrove and JC Stevenson

Wynn Department of Metabolic Medicine, Imperial College School of Medicine, National Heart and Lung Institute, London, UK.

Oestrogen is believed to possess cardiovascular protective properties. Endothelin-1 (ET-1) is a potent vasoconstrictor and mitogen for vascular smooth muscle cells. We have investigated release of ET-1 from human endothelial cells in response to 17 beta-oestradiol. Serum was found to stimulate significantly ET-1 release during the first 4 h of culture. 17 beta-Oestradiol significantly reduced ET-1 immunoreactivity in the media of treated cells by up to 49% of control values after 4 h. This effect was found to be inversely related to the dose of 17 beta-oestradiol. Significant dose-dependent increases in nitric oxide synthase expression were observed in response to oestrogen after 24 h but not after 4 h. Serum-free experiments demonstrated that low doses of oestrogen were able to inhibit thrombin-induced ET-1 release whilst supraphysiological levels did not. These results provide a further perspective on the ability of oestrogens to maintain vascular health.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S.-H. Juan, J.-J. Chen, C.-H. Chen, H. Lin, C.-F. Cheng, J.-C. Liu, M.-H. Hsieh, Y.-L. Chen, H.-H. Chao, T.-H. Chen, et al.
17{beta}-Estradiol inhibits cyclic strain-induced endothelin-1 gene expression within vascular endothelial cells
Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1254 - H1261.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
C. M. Webb, M. A. Ghatei, J. G. McNeill, DCRR, and P. Collins
17{beta}-Estradiol Decreases Endothelin-1 Levels in the Coronary Circulation of Postmenopausal Women With Coronary Artery Disease
Circulation, October 3, 2000; 102(14): 1617 - 1622.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
A.S. Bilsel, H. Moini, E. Tetik, F. Aksungar, B. Kaynak, and A. Ozer
17{beta}-Estradiol modulates endothelin-1 expression and release in human endothelial cells
Cardiovasc Res, June 1, 2000; 46(3): 579 - 584.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
X.-R. He, W. Wang, J. T. Crofton, and L. Share
Effects of 17beta -estradiol on the baroreflex control of sympathetic activity in conscious ovariectomized rats
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1999; 277(2): R493 - R498.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
H. V. O. Carswell, N. H. Anderson, J. S. Clark, D. Graham, B. Jeffs, A. F. Dominiczak, and I. M. Macrae
Genetic and Gender Influences on Sensitivity to Focal Cerebral Ischemia in the Stroke-Prone Spontaneously Hypertensive Rat
Hypertension, February 1, 1999; 33(2): 681 - 685.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 European Society of Endocrinology.